A healthcare technology company affected by the pandemic doesn't add up. The last two years could have been their best and only opportunity to make an impact. Palantir was awarded a £480 million contract by the NHS for a federated data platform. One should ask why Alcidion has not won any substantial contracts there. Is it due to poor UK leadership or a basic product offering? They havent won any substantial contracts in Australia as well since defence?
A healthcare technology company affected by the pandemic doesn't...
-
- There are more pages in this discussion • 533 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
